Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings.

Chen, Cheng-Pin

Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings. [electronic resource] - Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi Aug 2019 - 556-562 p. digital

Publication Type: Journal Article; Observational Study

1995-9133

10.1016/j.jmii.2018.10.002 doi


Adult
Antiviral Agents--economics
Coinfection--drug therapy
Cost-Benefit Analysis
Drug Therapy, Combination--economics
Female
Genotype
HIV Infections--complications
Health Care Costs
Hepatitis C, Chronic--complications
Humans
Male
Middle Aged
Prisons
Retrospective Studies
Ribavirin--economics
Taiwan
Viral Load